The Recall Desk

FDA (Devices) recall action 94909

Artivion, Inc recalled 2 products on 2024-08-14

The FDA (Devices) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2024-08-14
Critical
0
Units
2

Why these products were recalled

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

States named across these recalls

1–2 of 2

  • HighFDA (Devices)··2024-08-14

    Pulmonary Heart Valve Grafts Recalled Due to Invalid Test Results

    Artivion is recalling two CryoValve SG heart valve grafts that were approved and implanted with invalid test results.

    Product
    CryoValve SG Pulmonary Human Heart Valve, SGPV00, Cryopreserved Decellularized Heart Valve Allograft Prepared with SynerGraft (SG) Technology.
    Category
    Distribution
    4 states
  • HighFDA (Devices)··2024-08-14

    FDA Recalls CryoPatch Cardiac Tissue Grafts Due to Invalid Test Results

    Artivion has recalled CryoPatch SG cardiac tissue patches used in pulmonary surgeries due to approval and release with invalid test results. Patients who received implants should consult their healthcare provider.

    Product
    (1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tis
    Category
    Distribution
    4 states